Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,982.00
(
0.43%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
91.60
(
1.02%
)
Bitcoin
76,696.01
(
1.06%
)
News Focus
News Focus
Post# of 517462
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Investor2014

Send PM Follow Ignore
Followers 65
Posts 27742
Boards Moderated 0
Alias Born 11/23/2016

Investor2014

Re: Hosai post# 516502

Sunday, 03/29/2026 5:08:59 PM

Sunday, March 29, 2026 5:08:59 PM

Post# of 517462
You are elegantly ignoring that at the time of the rejection, a large Phase 3 trial (TRAILBLAZER-ALZ 2) was already ongoing and close to readout.

Lilly explicitly stated the Phase 3 readout was expected mid-2023 and would support a full approval filing.

Positive Phase 3 results were announced May 2023 (topline), showing significant slowing of decline.

Anavex have no such provisions in place and that is a problem. Do I have say again what I have said already too many times?

The longer we wait, the sooner we will get rich!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News